State-of-the-art in ligand-based virtual screening.
暂无分享,去创建一个
[1] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[2] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[3] J. Bajorath,et al. Identification of structurally diverse growth hormone secretagogue agonists by virtual screening and structure-activity relationship analysis of 2-formylaminoacetamide derivatives. , 2004, Journal of medicinal chemistry.
[4] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[5] G. Schneider,et al. Virtual Screening for Selective Allosteric mGluR1 Antagonists and Structure–Activity Relationship Investigations for Coumarine Derivatives , 2007, ChemMedChem.
[6] G. Schneider,et al. Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. , 2007, Journal of medicinal chemistry.
[7] C. Eyermann,et al. Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in gram-positive bacteria. , 2008, Bioorganic & medicinal chemistry letters.
[8] Ajay N. Jain,et al. Recommendations for evaluation of computational methods , 2008, J. Comput. Aided Mol. Des..
[9] The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach. , 2008, Bioorganic & medicinal chemistry letters.
[10] Nicolas Foloppe,et al. Discovery and functional evaluation of diverse novel human CB(1) receptor ligands. , 2009, Bioorganic & medicinal chemistry letters.
[11] Alexander M. Lewis,et al. Identification of a chemical probe for NAADP by virtual screening , 2009, Nature chemical biology.
[12] Hanna Geppert,et al. Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation , 2010, J. Chem. Inf. Model..
[13] J. Bajorath,et al. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. , 2010, Journal of medicinal chemistry.
[14] Gisbert Schneider,et al. Virtual screening: an endless staircase? , 2010, Nature Reviews Drug Discovery.
[15] Maria Paola Costi,et al. Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors. , 2010, Bioorganic & medicinal chemistry.
[16] G. Snyder,et al. Discovery of novel alpha7 nicotinic receptor antagonists. , 2010, Bioorganic & medicinal chemistry letters.
[17] Hanna Geppert,et al. Targeting multifunctional proteins by virtual screening: structurally diverse cytohesin inhibitors with differentiated biological functions. , 2010, ACS chemical biology.
[18] J. Bajorath,et al. Quo vadis, virtual screening? A comprehensive survey of prospective applications. , 2010, Journal of medicinal chemistry.